These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 28039944)

  • 1. Hydrochlorothiazide modulates ischemic heart failure-induced cardiac remodeling via inhibiting angiotensin II type 1 receptor pathway in rats.
    Luo J; Chen X; Luo C; Lu G; Peng L; Gao X; Zuo Z
    Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure.
    Luo J; Gao X; Peng L; Sun H; Dai G
    Eur J Pharmacol; 2011 Sep; 667(1-3):314-21. PubMed ID: 21703256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor.
    Zhang WW; Bai F; Wang J; Zheng RH; Yang LW; James EA; Zhao ZQ
    Drug Des Devel Ther; 2017; 11():3019-3033. PubMed ID: 29081650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats.
    Zhang RY; Wang LF; Zhang L; Meng XN; Li SJ; Wang WR
    Chin Med J (Engl); 2006 Apr; 119(8):649-55. PubMed ID: 16635409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
    Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
    Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tea Polyphenols Regulate Renin-angiotensin-aldosterone System and Transforming Growth Factor-β1/Smads Signaling Pathway in Heart Failure Rats].
    Wan LF; Yuan ZJ; Chen H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):384-391. PubMed ID: 35791933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
    Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
    Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression.
    Ma Y; Chen Y; Yang Y; Chen B; Liu D; Xiong Z; Zhang C; Dong Y
    Biochem Pharmacol; 2013 Jan; 85(2):223-33. PubMed ID: 23142711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of different Nox homologues to cardiac remodeling in two-kidney two-clip renovascular hypertensive rats: effect of valsartan.
    Wang P; Tang F; Li R; Zhang H; Chen S; Liu P; Huang H
    Pharmacol Res; 2007 May; 55(5):408-17. PubMed ID: 17324585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure.
    Milliez P; Messaoudi S; Nehme J; Rodriguez C; Samuel JL; Delcayre C
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H435-41. PubMed ID: 19074674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan inhibited angiotensin II-induced collagen metabolic imbalance without directly targeting TGF-β 1/Smad signaling pathway in cardiac fibroblasts.
    Zhang Y; Zhao NA; Wang JK; Zhu SM; Zhu HL; Liu B; Cui QW; Guan GC; Tian G
    Minerva Cardioangiol; 2015 Dec; 63(6):507-14. PubMed ID: 26657532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats.
    Seeland U; Kouchi I; Zolk O; Jockenhövel F; Itter G; Linz W; Böhm M
    Eur J Heart Fail; 2003 Jun; 5(3):241-6. PubMed ID: 12798820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW; Huang YW; Xia Q; Xu QW
    Chin Med J (Engl); 2005 Jan; 118(2):146-54. PubMed ID: 15667801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
    Chen K; Mehta JL; Li D; Joseph L; Joseph J
    Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
    de Boer RA; Pokharel S; Flesch M; van Kampen DA; Suurmeijer AJ; Boomsma F; van Gilst WH; van Veldhuisen DJ; Pinto YM
    J Mol Med (Berl); 2004 Oct; 82(10):678-87. PubMed ID: 15322702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway.
    Li C; Wang Y; Qiu Q; Shi T; Wu Y; Han J; Chai X; Wang W
    PLoS One; 2014; 9(8):e104255. PubMed ID: 25122164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRV120027, a novel β-arrestin biased ligand at the angiotensin II type I receptor, unloads the heart and maintains renal function when added to furosemide in experimental heart failure.
    Boerrigter G; Soergel DG; Violin JD; Lark MW; Burnett JC
    Circ Heart Fail; 2012 Sep; 5(5):627-34. PubMed ID: 22891045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of cardiac function and remodeling induced by myocardial infarction in rats are attenuated by the nonpeptide angiotensin-(1-7) analog AVE 0991.
    Zeng WT; Chen WY; Leng XY; Tang LL; Sun XT; Li CL; Dai G
    Cardiovasc Ther; 2012 Jun; 30(3):152-61. PubMed ID: 21167013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.